Mood Disorder Questionnaire (MDQ)

The Mood Disorder Questionnaire (MDQ) is a 15-item self-report screening instrument that can be used to identify clients most likely to have bipolar disorder. The MDQ assists in identifying bipolar disorder and distinguishing it from other mood disturbances in clinical populations.

Past research has found that MDQ total scores are associated with anxiety, trauma-related, substance use, eating, and impulse control disorders, in addition to BD (Paterniti & Bisserbe, 2018; Zimmerman et al., 2011). As a result, there have been two subscales identified (Carpenter et al., 2020):

  • Positive Activation: increased energy/activity, grandiosity, and decreased need for sleep. This subscale is specific to BD.
  • Negative Activation: irritability, racing thoughts, levels of negative affectivity, and distractibility. This subscale is more broadly related to emotion dysregulation and transdiagnostic personality traits.

Research indicates that effective treatment of bipolar disorder (BD) differs significantly from that of other related disorders, such as unipolar depression (Carpenter et al., 2020). This underscores the importance of screening for bipolar disorder (BD) in patients who present to mental health services so that they can receive an effective intervention. For example, the use of antidepressants in BD treatment is controversial (Sidor & MacQueen, 2011) and psychotherapy treatment more often involves addressing issues such as unrealistic goal-setting and impulsivity in patients with BD than in others (Geddes & Miklowitz, 2013; Miklowitz & Johnson, 2006). As BD is associated robustly with significant psychosocial impairment (e.g., poor work and relationship functioning), failing to detect cases of BD can lead to suboptimal treatment approaches and, thereby, exacerbate personal and societal costs associated with BD (Conus, Macneil, & McGorry, 2014).  

Mood Disorder Questionnaire questions

Developer

Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Jr, Lewis, L., McElroy, S. L., Post, R. M., Rapport, D. J., Russell, J. M., Sachs, G. S., & Zajecka, J. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. The American Journal of Psychiatry, 157(11), 1873–1875. https://doi.org/10.1176/appi.ajp.157.11.1873  

References

Carpenter, R. W., Stanton, K., Emery, N. N., & Zimmerman, M. (2020). Positive and Negative Activation in the Mood Disorder Questionnaire: Associations With Psychopathology and Emotion Dysregulation in a Clinical Sample. Assessment, 27(2), 219–231. https://doi.org/10.1177/1073191119851574

Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Jr, Lewis, L., McElroy, S. L., Post, R. M., Rapport, D. J., Russell, J. M., Sachs, G. S., & Zajecka, J. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. The American Journal of Psychiatry, 157(11), 1873–1875. https://doi.org/10.1176/appi.ajp.157.11.1873 

Stanton, K., & Watson, D. (2017). Explicating the structure and relations of the Mood Disorder Questionnaire: Implications for screening for bipolar and related disorders. Journal of Affective Disorders, 220, 72–78. https://doi.org/10.1016/j.jad.2017.05.046